Dec 28, 2022 | Blog, Shareholder Investigations
Kehoe Law Firm, P.C. is investigating whether the directors of Weber Inc. (“Weber”) (NYSE: WEBR) breached their fiduciary duties to Weber shareholders in approving a merger with affiliates of BDT Capital Partners, LLC (“BDT Capital”) for inadequate consideration.
The investigation concerns whether Weber’s board of directors failed to maximize the value of Weber for the benefit of Weber’s shareholders in connection with its announced merger with BDT Capital, in breach of their fiduciary duties to BDT Capital’s shareholders, and whether Weber’s shareholders have suffered damages as a result.
On December 11, 2022, Weber entered into an agreement to be bought out by BDT Capital for $8.05 per share in a transaction valued at approximately $3.7 billion.
WEBER INVESTORS ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. AND PROVIDE DETAILS OF THEIR TREAN INSURANCE SECURITIES.
WEBER SHAREHOLDERS ARE ALSO ENCOURAGED TO CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE INVESTIGATION AND FOR A FREE, NO-OBLIGATION EVALUATION OF POTENTIAL LEGAL CLAIMS.
Dec 28, 2022 | Blog, Shareholder Investigations
Kehoe Law Firm, P.C. is investigating whether the directors of Trean Insurance Group, Inc. (“Trean Insurance” or “Trean”) (NASDAQ: TIG) breached their fiduciary duties to the shareholders of Trean Insurance in approving a merger with affiliates of Altaris Capital Partners, LLC (“Altaris Capital”) for inadequate consideration.
The investigation concerns whether the board of directors of Trean Insurance failed to maximize the value of Trean for the benefit of its shareholders in connection with the announced merger with Altaris Capital, in breach of their fiduciary duties to Trean’s shareholders, and whether Trean’s shareholders have suffered financial damages as a result.
On December 15, 2022, Trean Insurance entered into an agreement to be bought out by Altaris for $6.15 per share. The transaction is valued at approximately $316 million.
INVESTORS OF TREAN INSURANCE ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. AND PROVIDE DETAILS OF THEIR TREAN INSURANCE SECURITIES.
TREAN INSURANCE SHAREHOLDERS ARE ALSO ENCOURAGED TO CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE INVESTIGATION AND FOR A FREE, NO-OBLIGATION EVALUATION OF POTENTIAL LEGAL CLAIMS.
Dec 5, 2022 | Blog, Shareholder Investigations
Kehoe Law Firm, P.C. is investigating whether certain directors and/or officers of Fulgent Genetics, Inc. (“Fulgent,” “Fulgent Genetics” or the “Company”) (NASDAQ: FLGT) breached their fiduciary duties to Fulgent and its shareholders by making, or causing Fulgent to make, false and/or misleading statements, in addition to failing to disclose material adverse facts, about Fulgent’s business, operations, prospects, and financial health.
INVESTORS OF FULGENT GENETICS SINCE AT LEAST AUGUST 4, 2022 ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C.
The investigation concerns whether the board failed to disclose material information, including whether Fulgent misled investors by failing to disclose that (i) Fulgent had been conducting medically unnecessary laboratory testing, engaging in improper billing practices in relation to laboratory testing, and providing or receiving remuneration in violation of the Anti-Kickback Statute and Stark Law; (ii) accordingly, Fulgent was likely to become subject to enhanced legal and regulatory scrutiny; and (iii) Fulgent’s revenues, to the extent they were derived from the foregoing unlawful conduct, were unsustainable; and whether, as a result, statements about Fulgent’s business, operations, and prospects lacked a reasonable basis.
On August 4, 2022, Fulgent released its second quarter 2022 financial results, disclosing that the SEC was conducting an investigation into certain of Fulgent’s reports filed with the SEC from 2018 through the first quarter 2020.
The disclosure followed Fulgent’s receipt of a civil investigative demand issued by the U.S. Department of Justice “related to its investigation of allegations of medically unnecessary laboratory testing, improper billing for laboratory testing, and remuneration received or provided in violation of the Anti-Kickback Statute and the Stark Law.”
On this news, Fulgent’s stock price fell $11.02, or 17.29%, over the following two trading sessions, to close at $52.72 per share on August 8, 2022.
IF YOU HAVE BEEN INVESTED IN FULGENT GENETICS STOCK SINCE AT LEAST AUGUST 4, 2022, YOU ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. AS YOU MAY HAVE LEGAL CLAIMS AGAINST THE DIRECTORS AND/OR OFFICERS OF THE COMPANY.
INVESTORS OF FULGENT GENETICS SINCE AT LEAST AUGUST 4, 2022 ARE ALSO ENCOURAGED TO CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Nov 20, 2022 | Blog, Shareholder Investigations
Kehoe Law Firm, P.C. is investigating whether the directors of Poshmark, Inc. (“Poshmark”) (NASDAQ: POSH) breached their fiduciary duties to its shareholders in approving a merger with NAVER Corporation (“NAVER”) for inadequate consideration.
The investigation concerns whether Poshmark’s board of directors failed to maximize the value of Poshmark for the benefit of Poshmark’s shareholders in connection with its announced merger with NAVER, in breach of their fiduciary duties to Poshmark’s shareholders, and whether Poshmark’s shareholders have suffered damages as a result.
On October 3, 2022, Poshmark announced it had reached an agreement to be bought out by NAVER for $17.90 per share. The transaction is valued at approximately $1.2 billion.
IF YOU INVESTED IN POSHMARK STOCK, YOU ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. AS YOU MAY HAVE LEGAL CLAIMS AGAINST POSHMARK’S DIRECTORS AND OFFICERS.
IF YOU WISH TO DISCUSS THIS INVESTIGATION, OR HAVE QUESTIONS ABOUT YOUR LEGAL RIGHTS, YOU ARE ALSO ENCOURAGED TO CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected].
Nov 20, 2022 | Blog, Shareholder Investigations
Kehoe Law Firm, P.C. is investigating whether certain directors and officers of Enviva Inc. (“Enviva”) (NYSE: EVA) breached their fiduciary duties to Enviva and its shareholders.
The investigation concerns whether members of Enviva’s board of directors or senior management failed to manage Enviva in an acceptable manner, in breach of their fiduciary duties, and whether Enviva and its shareholders have suffered damages as a result.
On October 12, 2022, Blue Orca Capital released a report stating that Enviva is overly reliant on capital raising to maintain its dividend, and that Enviva is engaging in “textbook greenwashing” regarding its wood pellet operations.
IF YOU INVESTED IN ENVIVA STOCK, YOU ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. AS YOU MAY HAVE LEGAL CLAIMS AGAINST ENVIVA’S DIRECTORS AND OFFICERS.
IF YOU WISH TO DISCUSS THIS INVESTIGATION, OR HAVE QUESTIONS ABOUT YOUR LEGAL RIGHTS, YOU ARE ALSO ENCOURAGED TO CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected].
Nov 17, 2022 | Blog, Shareholder Investigations
Provident Bancorp Stock: PVBC Shareholders Are Encouraged To Contact Kehoe Law Firm, P.C. To Discuss Potential Legal Claims
Kehoe Law Firm, P.C. is investigating whether Provident Bancorp (NASDAQ: PVBC) and/or its officers and directors violated securities laws and/or breached their fiduciary duties to Provident Bancorp and its shareholders.
INVESTORS OF PROVIDENT BANCORP STOCK ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. AND PROVIDE DETAILS ABOUT THEIR PVBC STOCK HOLDINGS.
IF YOU ARE AN INVESTOR OF PROVIDENT BANCORP, YOU ARE ENCOURAGED TO CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE INVESTIGATION AND POTENTIAL LEGAL CLAIMS WITHOUT COST OR OBLIGATION.
